XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.22.2.2

OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS | 9 Months Ended
--- | ---
Sep. 30, 2022
Stockholders' Equity Note [Abstract] |
OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS | OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS. The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended September 30, 2022 and 2021 are presented in the table below.
|  | Three months ended 9/30/2022 |  | Three months ended 9/30/2021 |  |
(in millions) |  | Equity method investments |  | Consolidated T. Rowe Price investment products - variable interest entities |  | Total currency translation adjustments |  | Equity method investments |  | Consolidated T. Rowe Price investment products - variable interest entities |  | Total currency translation adjustments |  |
Balances at beginning of period |  | $ | (39.9) |  |  | $ | (7.5) |  |  | $ | (47.4) |  |  | $ | (43.8) |  |  | $ | 15.1 |  |  | $ | (28.7) |  |  |
Other comprehensive income (loss) before reclassifications and income taxes |  | .7 |  |  | (12.7) |  |  | (12.0) |  |  | 3.5 |  |  | (5.0) |  |  | (1.5) |  |  |
Net deferred tax benefits (income taxes) |  | (.1) |  |  | 3.0 |  |  | 2.9 |  |  | (.4) |  |  | 1.2 |  |  | .8 |  |  |
Other comprehensive income (loss) |  | .6 |  |  | (9.7) |  |  | (9.1) |  |  | 3.1 |  |  | (3.8) |  |  | (.7) |  |  |
Balances at end of period |  | $ | (39.3) |  |  | $ | (17.2) |  |  | $ | (56.5) |  |  | $ | (40.7) |  |  | $ | 11.3 |  |  | $ | (29.4) |  |  |
The other comprehensive income (loss) in the table above excludes losses of $19.1 million and $12.2 million of other comprehensive income related to redeemable non-controlling interests held in our consolidated products for the three months ended September 30, 2022 and 2021, respectively. The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the nine months ended September 30, 2022 and 2021, are presented in the table below.
|  |  | Nine months ended 9/30/2022 |  | Nine months ended 9/30/2021
(in millions) |  |  | Equity method investments |  | Consolidated T. Rowe Price investment products - variable interest entities |  | Total currency translation adjustments |  | Equity method investments |  | Consolidated T. Rowe Price investment products - variable interest entities |  | Total currency translation adjustments
Balances at beginning of period |  |  | $ | (36.7) |  |  | $ | 10.2 |  |  | $ | (26.5) |  |  | $ | (43.6) |  |  | $ | 20.6 |  |  | $ | (23.0) |
Other comprehensive income (loss) before reclassifications and income taxes |  |  | (1.9) |  |  | (29.3) |  |  | (31.2) |  |  | 2.4 |  |  | (9.8) |  |  | (7.4) |
Reclassification adjustments recognized in non-operating income |  |  | — |  |  | (6.9) |  |  | (6.9) |  |  | — |  |  | (2.6) |  |  | (2.6) |
|  |  | (1.9) |  |  | (36.2) |  |  | (38.1) |  |  | 2.4 |  |  | (12.4) |  |  | (10.0) |
Net deferred tax benefits (income taxes) |  |  | (.7) |  |  | 8.8 |  |  | 8.1 |  |  | .5 |  |  | 3.1 |  |  | 3.6 |
Other comprehensive income (loss) |  |  | (2.6) |  |  | (27.4) |  |  | (30.0) |  |  | 2.9 |  |  | (9.3) |  |  | (6.4) |
Balances at end of period |  |  | $ | (39.3) |  |  | $ | (17.2) |  |  | $ | (56.5) |  |  | $ | (40.7) |  |  | $ | 11.3 |  |  | $ | (29.4) |
The other comprehensive income (loss) in the table above excludes losses of $44.6 million for the 2022 period and income of $20.2 million for the 2021 period of other comprehensive income (loss) related to redeemable non-controlling interests held in our consolidated products.

X
- Definition The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -URI https://asc.fasb.org/topic&trid=2134417 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(21)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(23)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 + Details
Name: | us-gaap_ComprehensiveIncomeNoteTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration